A comprehensive UC San Diego analysis of 11,000 youths reveals that adolescent marijuana use leads to a slower pace of cognitive development in memory, focus, and processing speed compared to non-users.
- Toxicology Over Self-Reporting: Unlike previous studies, researchers used biological testing, discovering that one in three young participants actively hid their cannabis use.
- Slower Cognitive Gains: While all teens showed natural brain development, those who used cannabis exhibited a noticeably slower rate of improvement in cognitive tasks.
- The CBD Nuance: Youth with CBD in their systems did not show the same cognitive slowing, though researchers caution this likely reflects lower THC exposure rather than a protective effect.
UC San Diego researchers have confirmed that adolescent marijuana use directly slows cognitive progress, including memory and focus. Analyzing data from 11,000 youths in a nationwide study, the findings highlight the neurological risks of cannabis exposure during crucial periods of teenage brain development.
Scheduled for publication in Neuropsychopharmacology, the research leverages data from the National Institutes of Health’s \$440 million Adolescent Brain Cognitive Development (ABCD) Study. Since 2016, the project has tracked children nationwide, starting at ages nine or ten.
Researchers administered biennial cognitive tests designed to stimulate brain regions vulnerable to adolescent marijuana use. These assessments measured skills like picture sequencing, pattern comparison, and verbal recall.
While all participants demonstrated cognitive improvement as they transitioned toward adulthood, the pace of progression was demonstrably slower for the 2,204 kids identified as cannabis users compared to the 9,664 who abstained. Lead author Natasha Wade noted that these findings strongly reinforce advice for parents to keep teens away from the drug until adulthood.
A defining feature of this study is its reliance on objective biological data rather than traditional, often unreliable, self-reporting.
- Biological Verification: Researchers utilized toxicological testing of urine, saliva, and hair to confirm cannabis exposure.
- Uncovering Hidden Use: The testing revealed that approximately one in three young participants did not voluntarily disclose their cannabis use to researchers.
- Strict Controls: The data was statistically adjusted to rule out confounding factors like prenatal cannabis exposure, mental health history, alcohol, and nicotine use.
Arizona State psychology professor Madeline Meier praised the toxicology approach but noted that occasional use isn’t expected to drive lasting changes, pointing instead to long-term, frequent use as the primary concern.
Interestingly, hair sample analysis revealed a divergence in outcomes based on the type of cannabis compounds present. Youth whose samples indicated the presence of cannabidiol (CBD) did not exhibit the same slower cognitive progress as the broader group of users.
However, Wade cautioned against assuming CBD offers neurological protection. She suggested that products high in CBD naturally contain lower levels of THC—the psychoactive compound responsible for the “high”—which might explain the better cognitive outcomes.
As the initial decade-long data collection phase concludes, researchers are pushing to renew the ABCD program for another five years to track participants into early adulthood. The primary challenge will be retaining the 11,000 participants as they graduate high school and disperse for college or careers.
For many participants, the long-term commitment is worth it. One youth, preparing for his biannual MRI scan, expressed a desire to continue even after moving out of state for college, noting the importance of showing “what happens when you do certain things and the repercussions.”